Establishing the psychometric underpinning of cognition measures for clinical trials of Alzheimer's disease and its precursors: A new approach

Alzheimer's and Dementia

Volumn 9, Issue 1 SUPPL., 2013, Pages

  Posner, Holly B ^a   Cano, Stefan ^b   Carrillo, Maria C ^c   Selnes, Ola ^d   Stern, Yaakov ^e   Thomas, Ronald G ^f   Zajicek, John ^a   Hobart, Jeremy ^a  

^a PFIZER INC   (United States)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

^c ALZHEIMER'S ASSOCIATION   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ADAS Cog; ADNI; Alzheimer's disease; Cognition; MCI; Neuropsychology; Psychometric

Indexed keywords

DONEPEZIL;

ALZHEIMER DISEASE; ARTICLE; CLINICAL TRIAL (TOPIC); COGNITION; COGNITIVE DEFECT; DISEASE SEVERITY; HUMAN; MILD COGNITIVE IMPAIRMENT; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOMETRY; WORD RECOGNITION;

ALZHEIMER DISEASE; CLINICAL TRIALS AS TOPIC; HUMANS; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; RESEARCH DESIGN;

EID: 84873371032     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2012.10.008     Document Type: Article

References (21)

1. R.C. Mohs, W.G. Rosen, and K.L. Davis The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy Psychopharmacol Bull 19 1983 448 450
2. W.G. Rosen, R.C. Mohs, and K.L. Davis A new rating scale for Alzheimer's disease Am J Psychiatry 141 1984 1356 1364
3. B. Dubois, H.H. Feldman, C. Jacova, S.T. Dekosky, P. Barberger-Gateau, and J. Cummings Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria Lancet Neurol 6 2007 734 746
4. J. Hobart, S. Cano, H. Posner, O. Selnes, Y. Stern, and R. Thomas Putting the Alzheimer's cognitive test to the test I: Traditional psychometric methods Alzheimers Dement 9 2012 S4 S9
5. J. Hobart, S. Cano, H. Posner, O. Selnes, Y. Stern, and R. Thomas Putting the Alzheimer's cognitive test to the test I: Rasch Measurement Theory Alzheimers Dement 9 2013 S10 S20
6. J. Inglis A paired-associate learning test for use with elderly psychiatric patients J Ment Sci 105 1959 440 443
7. A. Rey L'examen clinique en psychologie 1964 Presses Universitaires de France Paris
8. E.F. Kaplan, H. Goodglass, and S. Weintraub Boston Naming Test 1983 Lea & Febiger Philadelphia, PA
9. J.C. Hobart, S.J. Cano, J.P. Zajicek, and A.J. Thompson Rating scales as outcome measures for clinical trials in neurology: problems, solutions, and recommendations Lancet Neurol 6 2007 1094 1105
10. J. Hobart, and S. Cano Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods Health Technol Assess 13 2009 1 177
11. P.M. Doraiswamy, L. Kaiser, F. Bieber, and R.L. Garman The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease Alzheimer Dis Assoc Disord 15 2001 174 183
12. G. Weyer, H. Erzigkeit, S. Kanowski, R. Ihl, and D. Hadler Alzheimer's Disease Assessment Scale: reliability and validity in a multicenter clinical trial Int Psychogeriatr 9 1997 123 138
13. K.N. Lohr Assessing health status and quality-of-life instruments: attributes and review criteria Qual Life Res 11 2002 193 205
14. S.J. Cano, H.B. Posner, M.L. Moline, S.W. Hurt, J. Swartz, and T. Hsu The ADAS-Cog in Alzheimer's disease clinical trials: psychometric evaluation of the sum and its parts J Neurol Neurosurg Psychiatry 81 2010 1363 1368
15. R.C. Mohs, D. Knopman, R.C. Petersen, S.H. Ferris, C. Ernesto, and M. Grundman Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope: the Alzheimer's Disease Cooperative Study Alzheimer Dis Assoc Disord 11 1997 S13 S21
16. D.P. Salmon Neuropsychological features of mild cognitive impairment and preclinical Alzheimer's disease M.C. Pardon, M.W. Bondi, Behavioral Neurobiology of Aging Volume 10 2012 Springer Berlin Heidelberg 187 212
17. H. Wouters, B. Appels, W.M. van der Flier, J. van Campen, M. Klein, and A.H. Zwinderman Improving the accuracy and precision of cognitive testing in mild dementia J Int Neuropsychol Soc 18 2012 314 322
18. D. Andrich Rating scales and Rasch measurement Expert Rev Pharmacoecon Outcomes Res 11 2011 571 585
19. Rasch G. On general laws and the meaning of measurement in psychology. In: Proceedings of the Fourth Berkeley Symposium on Mathematical Statistics and Probability, IV. Berkeley, CA: University Of California Press; 1961;4:321-33.
20. S.J. Cano, L.E. Barrett, J.P. Zajicek, and J.C. Hobart Beyond the reach of traditional analyses: using Rasch to evaluate the DASH in people with multiple sclerosis Mult Scler 17 2010 214 222
21. J.C. Hobart, H.B. Posner, P. Aisen, O. Selnes, Y. Stern, and R. Thomas The ADAS-Cog's performance as a measure: lessons from the ADNI study. Part 3: do the scale modifications add value? Neurology 72 2009 A92